Loading…
Reported covered position: Staff Director/Chief Counsel, Senate Judiciary Committee; Analyst, Senate Budget Committee; Counsel, Legislative Assistant, Special Assistant to Chief Staff, Senator Kent Conrad
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Increasing Access to Biosimilars Act of 2023
Client: VIATRIS INC · Firm: WEST FRONT STRATEGIES LLC
Issues related to access to biosimilar biological products in Medicare Part B, including the Increasing Access to Biosimilars Act, H.R. 1352.
Increasing Access to Biosimilars Act of 2023
Client: VIATRIS INC · Firm: WEST FRONT STRATEGIES LLC
Issues related to access to biosimilar biological products in Medicare Part B, including the Increasing Access to Biosimilars Act, H.R. 1352.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
BROWN-FORMAN via WEST FRONT STRATEGIES LLC
2025 · fourth_quarter · 4T
Issues related to tariffs, including duty drawbacks
Issues related to corporate tax policy.
Source: Senate LDA
| WALGREEN CO |
| 24 |
| 2019–2024 |
| CENTER FOR RESPONSIBLE LENDING | 23 | 2019–2024 |
| COMCAST CORPORATION | 22 | 2019–2024 |
| UNITED FOR PATENT REFORM | 22 | 2019–2024 |
| VAPOR TECHNOLOGY ASSOCIATION | 21 | 2019–2024 |
| ENVIRONMENTAL DEFENSE ACTION FUND | 18 | 2019–2023 |
| INTERNATIONAL LEGAL FINANCE ASSOCIATION | 18 | 2021–2024 |
| YWCA USA | 18 | 2019–2023 |
| ALLIANCE FOR SAFETY AND JUSTICE | 17 | 2021–2024 |
| EXPEDIA, INC. | 17 | 2019–2024 |
| INTEL CORPORATION | 16 | 2019–2022 |
| LOWE'S COMPANIES INC | 16 | 2020–2024 |
| BRIGHTHOUSE FINANCIAL | 15 | 2020–2024 |
| CTIA - THE WIRELESSS ASSOCIATION | 15 | 2021–2024 |
| PLEASE TOUCH MUSEUM | 15 | 2021–2024 |
| VIZIO | 15 | 2020–2024 |
| NATIONAL INSURANCE CRIME BUREAU | 14 | 2021–2024 |
| Fresenius Kabi USA, LLC | 13 | 2022–2024 |
| VELATURA PUBLIC BENEFIT CORPORATION | 13 | 2022–2024 |
| MICROSOFT CORPORATION | 12 | 2022–2024 |
| ANYWHERE REAL ESTATE INC. (FKA REALOGY HOLDINGS CORP.) | 9 | 2021–2022 |
| SKY MARKETING LLC | 9 | 2022–2024 |
| THE PNC FINANCIAL SERVICES GROUP | 9 | 2022–2024 |
| The Chicago School of Professional Psychology | 9 | 2023–2024 |
| DAVITA INC. | 7 | 2023–2024 |
| RTX CORPORATION AND AFFILIATES | 7 | 2023–2024 |
| BOEING COMPANY | 6 | 2021–2024 |
| CIGAR ASSOCIATION OF AMERICA | 6 | 2023–2024 |
| OLEARY PRODUCTIONS USA LLC | 6 | 2023–2024 |
| TESLA INC. | 6 | 2019–2020 |
| BLINK HEALTH INC. | 5 | 2023–2024 |
| COALITION OF MANUFACTURERS OF SMOKING ALTERNATIVES | 5 | 2024 |
| LIBERTY SBF | 3 | 2020 |
| PRUDENTIAL FINANCIAL INC | 3 | 2024 |
| SODEXO | 3 | 2020–2021 |
| HAMMES COMPANY | 2 | 2020 |
Prescription Information Modernization Act of 2023
Client: VIATRIS INC · Firm: WEST FRONT STRATEGIES LLC
Issues related to drug pricing; issues related to pharmaceutical supply chain; issues related to modernization of prescribing information for physicians and pharmacists; Improved Access to Affordable Medications Act, S. 1120; Increasing Transparency in Generic Drug Applications, S.775 and HR 3839; Part D Formulary Design and Generic Drug Tiering; Prescription Information Modernization Act, HR 1503; and Presidents Emergency Plan for AIDS Relief Reauthorization.
Prescription Information Modernization Act of 2023
Client: VIATRIS INC · Firm: WEST FRONT STRATEGIES LLC
Issues related to drug pricing; issues related to pharmaceutical supply chain; issues related to modernization of prescribing information for physicians and pharmacists; Improved Access to Affordable Medications Act, S. 1120; Increasing Transparency in Generic Drug Applications, S.775 and HR 3839; Part D Formulary Design and Generic Drug Tiering; Prescription Information Modernization Act, HR 1503; and Presidents Emergency Plan for AIDS Relief Reauthorization.
Prescription Information Modernization Act of 2023
Client: VIATRIS INC · Firm: WEST FRONT STRATEGIES LLC
Issues related to drug pricing; issues related to pharmaceutical supply chain; issues related to modernization of prescribing information for physicians and pharmacists; Improved Access to Affordable Medications Act, S. 1120; Increasing Transparency in Generic Drug Applications, S.775 and HR 3839; Part D Formulary Design and Generic Drug Tiering; Prescription Information Modernization Act, HR 1503.
Prescription Information Modernization Act of 2023
Client: VIATRIS INC · Firm: WEST FRONT STRATEGIES LLC
Issues related to drug pricing; issues related to pharmaceutical supply chain; issues related to modernization of prescribing information for physicians and pharmacists; Improved Access to Affordable Medications Act, S. 1120; Increasing Transparency in Generic Drug Applications, S.775 and HR 3839; Part D Formulary Design and Generic Drug Tiering; Prescription Information Modernization Act, HR 1503.
Interagency Patent Coordination and Improvement Act of 2023
Client: VIATRIS INC · Firm: WEST FRONT STRATEGIES LLC
Issues related to Inter Partes Review and patent policy generally; Preserve Access to Affordable Generics and Biosimilars Act, S.142; Affordable Prescriptions for Patients Act, S. 150 Issues related to FDA and PTO coordination, including, Interagency Patent Coordination and Improvement Act of 2023 (S. 79 and HR 1717) and Medication Affordability and Patent Integrity Act (S.2780 and HR 5429); PREVAIL Act (S.2220 and HR 4370).
Interagency Patent Coordination and Improvement Act of 2023
Client: VIATRIS INC · Firm: WEST FRONT STRATEGIES LLC
Issues related to Inter Partes Review and patent policy generally; Preserve Access to Affordable Generics and Biosimilars Act, S.142; Affordable Prescriptions for Patients Act, S. 150 Issues related to FDA and PTO coordination, including, Interagency Patent Coordination and Improvement Act of 2023, S. 79 and HR 1717, and Medication Affordability and Patent Integrity Act, S.2780 and HR 5429; PREVAIL Act, S.2220 and HR 4370; Patent Eligibility Restoration Act of 2023, S.2140.
Interagency Patent Coordination and Improvement Act of 2023
Client: VIATRIS INC · Firm: WEST FRONT STRATEGIES LLC
Issues related to Inter Partes Review and patent policy generally; Preserve Access to Affordable Generics and Biosimilars Act, S.142; Affordable Prescriptions for Patients Act, S. 150 Issues related to FDA and PTO coordination, including, Interagency Patent Coordination and Improvement Act of 2023 (S. 79 and HR 1717) and Medication Affordability and Patent Integrity Act (S.2780 and HR 5429); PREVAIL Act (S.2220 and HR 4370).
Interagency Patent Coordination and Improvement Act of 2023
Client: VIATRIS INC · Firm: WEST FRONT STRATEGIES LLC
Issues related to Inter Partes Review and patent policy generally; Preserve Access to Affordable Generics and Biosimilars Act, S.142; Affordable Prescriptions for Patients Act, S. 150 Issues related to FDA and PTO coordination, including, Interagency Patent Coordination and Improvement Act of 2023, S. 79 and HR 1717, and Medication Affordability and Patent Integrity Act, S.2780 and HR 5429; PREVAIL Act, S.2220 and HR 4370; Patent Eligibility Restoration Act of 2023, S.2140.
Equitable Community Access to Pharmacist Services Act
Client: WALGREEN CO. · Firm: WEST FRONT STRATEGIES LLC
Issues related to pharmacy, military pharmacies, pharmacist provider status, and Medicare reimbursement, including Equitable Community Access to Pharmacist Services Act (H.R. 1770 and S. 2447)).
Equitable Community Access to Pharmacist Services Act
Client: WALGREEN CO. · Firm: WEST FRONT STRATEGIES LLC
Issues related to pharmacy, military pharmacies, pharmacist provider status, and Medicare reimbursement, including Equitable Community Access to Pharmacist Services Act (H.R. 1770 and S. 2447)).
Equitable Community Access to Pharmacist Services Act
Client: WALGREEN CO. · Firm: WEST FRONT STRATEGIES LLC
Issues related to pharmacy, military pharmacies, pharmacist provider status, and Medicare reimbursement, including Equitable Community Access to Pharmacist Services Act (H.R. 1770 and S. 2477).
Equitable Community Access to Pharmacist Services Act
Client: WALGREEN CO. · Firm: WEST FRONT STRATEGIES LLC
Issues related to pharmacy, military pharmacies, pharmacist provider status, and Medicare reimbursement, including Equitable Community Access to Pharmacist Services Act (H.R. 1770 and S. 2477).
Primary Care Enhancement Act of 2023
Client: BOEING COMPANY · Firm: WEST FRONT STRATEGIES LLC
Primary Care Enhancement Act of 2023, H.R. 3029 and S. 628.
Primary Care Enhancement Act of 2023
Client: BOEING COMPANY · Firm: WEST FRONT STRATEGIES LLC
Primary Care Enhancement Act of 2023, H.R. 3029 and S. 628.
Primary Care Enhancement Act of 2023
Client: BOEING COMPANY · Firm: WEST FRONT STRATEGIES LLC
Primary Care Enhancement Act of 2023, H.R. 3029 and S. 628.
AM Radio for Every Vehicle Act of 2023
Client: CONSUMER TECHNOLOGY ASSOCIATION · Firm: WEST FRONT STRATEGIES LLC
AM Radio for Every Vehicle Act of 2023 (H.R.3413 and S. 1669); monitor issues related to Section 230 of the Communications Act of 1934.
AM Radio for Every Vehicle Act of 2023
Client: CONSUMER TECHNOLOGY ASSOCIATION · Firm: WEST FRONT STRATEGIES LLC
AM Radio for Every Vehicle Act of 2023 (H.R.3413 and S. 1669); monitor issues related to Section 230 of the Communications Act of 1934.
AM Radio for Every Vehicle Act of 2023
Client: CONSUMER TECHNOLOGY ASSOCIATION · Firm: WEST FRONT STRATEGIES LLC
AM Radio for Every Vehicle Act of 2023 (H.R.3413 and S. 1669); monitor issues related to Section 230 of the Communications Act of 1934.
AM Radio for Every Vehicle Act of 2023
Client: CONSUMER TECHNOLOGY ASSOCIATION · Firm: WEST FRONT STRATEGIES LLC
AM Radio for Every Vehicle Act of 2023 (H.R.3413 and S. 1669); monitor issues related to Section 230 of the Communications Act of 1934.
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: VIATRIS INC · Firm: WEST FRONT STRATEGIES LLC
Issues related to drug pricing; issues related to pharmaceutical supply chain; issues related to modernization of prescribing information for physicians and pharmacists; Improved Access to Affordable Medications Act, S. 1120; Increasing Transparency in Generic Drug Applications, S.775 and HR 3839; Part D Formulary Design and Generic Drug Tiering; Prescription Information Modernization Act, HR 1503; and Presidents Emergency Plan for AIDS Relief Reauthorization.
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: VIATRIS INC · Firm: WEST FRONT STRATEGIES LLC
Issues related to drug pricing; issues related to pharmaceutical supply chain; issues related to modernization of prescribing information for physicians and pharmacists; Improved Access to Affordable Medications Act, S. 1120; Increasing Transparency in Generic Drug Applications, S.775 and HR 3839; Part D Formulary Design and Generic Drug Tiering; Prescription Information Modernization Act, HR 1503; and Presidents Emergency Plan for AIDS Relief Reauthorization.
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: VIATRIS INC · Firm: WEST FRONT STRATEGIES LLC
Issues related to drug pricing; issues related to pharmaceutical supply chain; issues related to modernization of prescribing information for physicians and pharmacists; Improved Access to Affordable Medications Act, S. 1120; Increasing Transparency in Generic Drug Applications, S.775 and HR 3839; Part D Formulary Design and Generic Drug Tiering; Prescription Information Modernization Act, HR 1503.
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Client: VIATRIS INC · Firm: WEST FRONT STRATEGIES LLC
Issues related to drug pricing; issues related to pharmaceutical supply chain; issues related to modernization of prescribing information for physicians and pharmacists; Improved Access to Affordable Medications Act, S. 1120; Increasing Transparency in Generic Drug Applications, S.775 and HR 3839; Part D Formulary Design and Generic Drug Tiering; Prescription Information Modernization Act, HR 1503.
END CELLS in CELLS Act
Client: CTIA - THE WIRELESS ASSOCIATION · Firm: WEST FRONT STRATEGIES LLC
Issues related to wireless policy, including spectrum, broadband funding, 5G, and privacy; issues related to the use of contraband phones in correctional facilities, including End Cells in Cells, HR 3949; Cooper Davis Act, S. 1080; issues related to the Affordable Connectivity Program issues related to net neutrality regulation.
END CELLS in CELLS Act
Client: CTIA - THE WIRELESS ASSOCIATION · Firm: WEST FRONT STRATEGIES LLC
Issues related to wireless policy, including spectrum, broadband funding, 5G, and privacy; issues related to the use of contraband phones in correctional facilities, including End Cells in Cells, HR 3949; Cooper Davis Act, S. 1080; issues related to the Affordable Connectivity Program issues related to net neutrality regulation.
END CELLS in CELLS Act
Client: CTIA - THE WIRELESS ASSOCIATION · Firm: WEST FRONT STRATEGIES LLC
Monitor issues related to wireless policy, including broadband funding, 5G, and privacy; issues related to the use of contraband phones in correctional facilities, including End Cells in Cells, HR 3949 and Cooper Davis Act, S. 1080; issues related to the Affordable Connectivity Program issues related to net neutrality regulation.
END CELLS in CELLS Act
Client: CTIA - THE WIRELESS ASSOCIATION · Firm: WEST FRONT STRATEGIES LLC
Monitor issues related to wireless policy, including broadband funding, 5G, and privacy; issues related to the use of contraband phones in correctional facilities, including End Cells in Cells, HR 3949 and Cooper Davis Act, S. 1080; issues related to the Affordable Connectivity Program issues related to net neutrality regulation.
Issues related to tariffs, including duty drawbacks; Duty Drawback Clarification Act (S. 1781 and HR 4073).
Issues related to tariffs, including duty drawbacks; Duty Drawback Clarification Act (S. 1781 and HR 4073).
Issues related to tariffs, including duty drawbacks; Duty Drawback Clarification Act (S. 1781 and HR 4073).
Issues related to corporate tax policy, including duty drawbacks; Duty Drawback Clarification Act (S. 1781 and HR 4073).
Issues related to tariffs, including duty drawbacks; Duty Drawback Clarification Act (S. 1781 and HR 4073).
Issues related to corporate tax policy, including duty drawbacks; Duty Drawback Clarification Act (S. 1781 and HR 4073).
Issues related to corporate tax policy, including duty drawbacks; Duty Drawback Clarification Act (S. 1781 and HR 4073).
Issues related to corporate tax policy, including duty drawbacks; Duty Drawback Clarification Act (S. 1781 and HR 4073).
Issues related to patent law, including the Promoting and Respecting Economically Vital American Innovation Leadership (S. 2220 and HR 4370) and the Patent Eligibility Restoration Act (S. 2140).
Issues relating to patent policy including Inter Partes Review and institution decisions, patent quality, communication between patent examiners and the Patent Trial and Appeal Board (PTAB), PTAB generally, and patent eligibility; Patent Eligibility Restoration Act of 2023 (S. 2140 and HR 9474); Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (S. 2220 and HR 4370); RESTORE Patent Rights Act of 2024 (S. 4840 and HR 9221).
Issues related to Inter Partes Review and patent policy generally; Preserve Access to Affordable Generics and Biosimilars Act, S.142; Affordable Prescriptions for Patients Act, S. 150 Issues related to FDA and PTO coordination, including, Interagency Patent Coordination and Improvement Act of 2023 (S. 79 and HR 1717) and Medication Affordability and Patent Integrity Act (S.2780 and HR 5429); PREVAIL Act (S.2220 and HR 4370).
Issues related to patent policy and reform, including to address patent thickets (HR 6986, S. 3583) and Promoting and Respecting Economically Vital American Innovation Leadership Act (S. 2220, HR 4370), and Patent Eligibility Restoration Act of 2023 (S. 2140) FDA/PTO Coordination, including Interagency Patent Coordination and Improvement Act of 2023 (S.79) and Medication Affordability and Patent Integrity Act (S. 2780, HR 5429) Prescription Pricing for the People Act of 2023 (S.113); Preserve Access to Affordable Generics and Biosimilars Act (S.142); Affordable Prescriptions for Patients Act of 2023 (S.150).
Issues related to Inter Partes Review and patent policy generally; Preserve Access to Affordable Generics and Biosimilars Act, S.142; Affordable Prescriptions for Patients Act, S. 150 Issues related to FDA and PTO coordination, including, Interagency Patent Coordination and Improvement Act of 2023, S. 79 and HR 1717, and Medication Affordability and Patent Integrity Act, S.2780 and HR 5429; PREVAIL Act, S.2220 and HR 4370; Patent Eligibility Restoration Act of 2023, S.2140.
Issues related to patent policy and reform, including to address patent thickets (HR 6986, S. 3583) and Promoting and Respecting Economically Vital American Innovation Leadership Act (S. 2220, HR 4370), and Patent Eligibility Restoration Act of 2023 (S. 2140) FDA/PTO Coordination, including Interagency Patent Coordination and Improvement Act of 2023 (S.79) and Medication Affordability and Patent Integrity Act (S. 2780, HR 5429) Prescription Pricing for the People Act of 2023 (S.113); Preserve Access to Affordable Generics and Biosimilars Act (S.142); Affordable Prescriptions for Patients Act of 2023 (S.150).
Issues related to patent policy and reform, including to address patent thickets (HR 6986, S. 3583) and Promoting and Respecting Economically Vital American Innovation Leadership Act (S. 2220, HR 4370), and Patent Eligibility Restoration Act of 2023 (S. 2140) FDA/PTO Coordination, including Interagency Patent Coordination and Improvement Act of 2023 (S.79) and Medication Affordability and Patent Integrity Act (S. 2780, HR 5429) Prescription Pricing for the People Act of 2023 (S.113); Preserve Access to Affordable Generics and Biosimilars Act (S.142); Affordable Prescriptions for Patients Act of 2023 (S.150).
Issues related to patent law, including the Promoting and Respecting Economically Vital American Innovation Leadership (S. 2220 and HR 4370) and the Patent Eligibility Restoration Act (S. 2140).
Issues related to Inter Partes Review and patent policy generally; Preserve Access to Affordable Generics and Biosimilars Act, S.142; Affordable Prescriptions for Patients Act, S. 150 Issues related to FDA and PTO coordination, including, Interagency Patent Coordination and Improvement Act of 2023 (S. 79 and HR 1717) and Medication Affordability and Patent Integrity Act (S.2780 and HR 5429); PREVAIL Act (S.2220 and HR 4370).
Issues related to patent law, including the Promoting and Respecting Economically Vital American Innovation Leadership (S. 2220 and HR 4370) and the Patent Eligibility Restoration Act (S. 2140).
Issues relating to patent policy including Inter Partes Review and institution decisions, patent quality, communication between patent examiners and the Patent Trial and Appeal Board (PTAB), PTAB generally, and patent eligibility; Patent Eligibility Restoration Act of 2023 (S. 2140 and HR 9474); Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (S. 2220 and HR 4370); RESTORE Patent Rights Act of 2024 (S. 4840 and HR 9221).
Issues related to patent law, including the Promoting and Respecting Economically Vital American Innovation Leadership (S. 2220 and HR 4370) and the Patent Eligibility Restoration Act (S. 2140).
Issues related to Inter Partes Review and patent policy generally; Preserve Access to Affordable Generics and Biosimilars Act, S.142; Affordable Prescriptions for Patients Act, S. 150 Issues related to FDA and PTO coordination, including, Interagency Patent Coordination and Improvement Act of 2023, S. 79 and HR 1717, and Medication Affordability and Patent Integrity Act, S.2780 and HR 5429; PREVAIL Act, S.2220 and HR 4370; Patent Eligibility Restoration Act of 2023, S.2140.
Issues related to patent policy and reform, including to address patent thickets (HR 6986, S. 3583) and Promoting and Respecting Economically Vital American Innovation Leadership Act (S. 2220, HR 4370), and Patent Eligibility Restoration Act of 2023 (S. 2140) FDA/PTO Coordination, including Interagency Patent Coordination and Improvement Act of 2023 (S.79) and Medication Affordability and Patent Integrity Act (S. 2780, HR 5429) Prescription Pricing for the People Act of 2023 (S.113); Preserve Access to Affordable Generics and Biosimilars Act (S.142); Affordable Prescriptions for Patients Act of 2023 (S.150).
Issues related to the Medicare Secondary Payer Act, including HR 6860 and S. 5018, Restore Protections for Dialysis Patients Act; Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act, H.R. 5074/S. 4510; issues related to home dialysis.
Medication Affordability and Patent Integrity Act
Client: VIATRIS INC · Firm: WEST FRONT STRATEGIES LLC
Issues related to Inter Partes Review and patent policy generally; Preserve Access to Affordable Generics and Biosimilars Act, S.142; Affordable Prescriptions for Patients Act, S. 150 Issues related to FDA and PTO coordination, including, Interagency Patent Coordination and Improvement Act of 2023 (S. 79 and HR 1717) and Medication Affordability and Patent Integrity Act (S.2780 and HR 5429); PREVAIL Act (S.2220 and HR 4370).
Medication Affordability and Patent Integrity Act
Client: FRESENIUS KABI USA LLC · Firm: WEST FRONT STRATEGIES LLC
Issues related to patent policy and reform, including to address patent thickets (HR 6986, S. 3583) and Promoting and Respecting Economically Vital American Innovation Leadership Act (S. 2220, HR 4370), and Patent Eligibility Restoration Act of 2023 (S. 2140) FDA/PTO Coordination, including Interagency Patent Coordination and Improvement Act of 2023 (S.79) and Medication Affordability and Patent Integrity Act (S. 2780, HR 5429) Prescription Pricing for the People Act of 2023 (S.113); Preserve Access to Affordable Generics and Biosimilars Act (S.142); Affordable Prescriptions for Patients Act of 2023 (S.150).
Medication Affordability and Patent Integrity Act
Client: FRESENIUS KABI USA LLC · Firm: WEST FRONT STRATEGIES LLC
Issues related to patent policy and reform, including to address patent thickets (HR 6986, S. 3583) and Promoting and Respecting Economically Vital American Innovation Leadership Act (S. 2220, HR 4370), and Patent Eligibility Restoration Act of 2023 (S. 2140) FDA/PTO Coordination, including Interagency Patent Coordination and Improvement Act of 2023 (S.79) and Medication Affordability and Patent Integrity Act (S. 2780, HR 5429) Prescription Pricing for the People Act of 2023 (S.113); Preserve Access to Affordable Generics and Biosimilars Act (S.142); Affordable Prescriptions for Patients Act of 2023 (S.150).
Medication Affordability and Patent Integrity Act
Client: FRESENIUS KABI USA LLC · Firm: WEST FRONT STRATEGIES LLC
Issues related to patent policy and reform, including to address patent thickets (HR 6986, S. 3583) and Promoting and Respecting Economically Vital American Innovation Leadership Act (S. 2220, HR 4370), and Patent Eligibility Restoration Act of 2023 (S. 2140) FDA/PTO Coordination, including Interagency Patent Coordination and Improvement Act of 2023 (S.79) and Medication Affordability and Patent Integrity Act (S. 2780, HR 5429) Prescription Pricing for the People Act of 2023 (S.113); Preserve Access to Affordable Generics and Biosimilars Act (S.142); Affordable Prescriptions for Patients Act of 2023 (S.150).
Medication Affordability and Patent Integrity Act
Client: FRESENIUS KABI USA LLC · Firm: WEST FRONT STRATEGIES LLC
Issues related to patent policy and reform, including to address patent thickets (HR 6986, S. 3583) and Promoting and Respecting Economically Vital American Innovation Leadership Act (S. 2220, HR 4370), and Patent Eligibility Restoration Act of 2023 (S. 2140) FDA/PTO Coordination, including Interagency Patent Coordination and Improvement Act of 2023 (S.79) and Medication Affordability and Patent Integrity Act (S. 2780, HR 5429) Prescription Pricing for the People Act of 2023 (S.113); Preserve Access to Affordable Generics and Biosimilars Act (S.142); Affordable Prescriptions for Patients Act of 2023 (S.150).
Medication Affordability and Patent Integrity Act
Client: VIATRIS INC · Firm: WEST FRONT STRATEGIES LLC
Issues related to Inter Partes Review and patent policy generally; Preserve Access to Affordable Generics and Biosimilars Act, S.142; Affordable Prescriptions for Patients Act, S. 150 Issues related to FDA and PTO coordination, including, Interagency Patent Coordination and Improvement Act of 2023, S. 79 and HR 1717, and Medication Affordability and Patent Integrity Act, S.2780 and HR 5429; PREVAIL Act, S.2220 and HR 4370; Patent Eligibility Restoration Act of 2023, S.2140.
Medication Affordability and Patent Integrity Act
Client: VIATRIS INC · Firm: WEST FRONT STRATEGIES LLC
Issues related to Inter Partes Review and patent policy generally; Preserve Access to Affordable Generics and Biosimilars Act, S.142; Affordable Prescriptions for Patients Act, S. 150 Issues related to FDA and PTO coordination, including, Interagency Patent Coordination and Improvement Act of 2023, S. 79 and HR 1717, and Medication Affordability and Patent Integrity Act, S.2780 and HR 5429; PREVAIL Act, S.2220 and HR 4370; Patent Eligibility Restoration Act of 2023, S.2140.
Medication Affordability and Patent Integrity Act
Client: VIATRIS INC · Firm: WEST FRONT STRATEGIES LLC
Issues related to Inter Partes Review and patent policy generally; Preserve Access to Affordable Generics and Biosimilars Act, S.142; Affordable Prescriptions for Patients Act, S. 150 Issues related to FDA and PTO coordination, including, Interagency Patent Coordination and Improvement Act of 2023 (S. 79 and HR 1717) and Medication Affordability and Patent Integrity Act (S.2780 and HR 5429); PREVAIL Act (S.2220 and HR 4370).
FAST PASS Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: WEST FRONT STRATEGIES LLC
Issues related to the distribution of health care products; issues related to pandemic preparedness, including reauthorization of the Pandemic and All Hazards Preparedness Act; issues related to supply chain security and transportation of medical supplies; issues related to the expedition of critical medical supplies at US ports, including FAST PASS Act - HR 6140, and Section 3522 of Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 - H.R. 8070.
FAST PASS Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: WEST FRONT STRATEGIES LLC
Issues related to the distribution of health care products; issues related to pandemic preparedness, including reauthorization of the Pandemic and All Hazards Preparedness Act; issues related to supply chain security and transportation of medical supplies; issues related to the expedition of critical medical supplies at US ports including FAST PASS Act (HR 6140).
FAST PASS Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: WEST FRONT STRATEGIES LLC
Issues related to the distribution of health care products; issues related to pandemic preparedness, including reauthorization of the Pandemic and All Hazards Preparedness Act; issues related to supply chain security and transportation of medical supplies; issues related to the expedition of critical medical supplies at US ports including FAST PASS Act (HR 6140).
FAST PASS Act
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: WEST FRONT STRATEGIES LLC
Issues related to the distribution of health care products; issues related to pandemic preparedness, including reauthorization of the Pandemic and All Hazards Preparedness Act; issues related to supply chain security and transportation of medical supplies; issues related to the expedition of critical medical supplies at US ports, including FAST PASS Act - HR 6140, and Section 3522 of Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 - H.R. 8070.
Issues related to drug pricing; issues related to Biosimilars; issues related to competition; issues related to drug shortages; DRUG Act (HR 6283, S. 1542).
Issues related to drug pricing; issues related to Biosimilars; issues related to competition; issues related to drug shortages; DRUG Act (HR 6283, S. 1542).
Issues related to drug pricing; issues related to Biosimilars; issues related to competition; issues related to drug shortages; DRUG Act (HR 6283, S. 1542).
Issues related to drug pricing; issues related to Biosimilars; issues related to competition; issues related to drug shortages; DRUG Act (HR 6283, S. 1542).
Restore Protections for Dialysis Patients Act
Client: DAVITA INC. · Firm: WEST FRONT STRATEGIES LLC
Issues related to the Medicare Secondary Payer Act, including HR 6860 and S. 5018, Restore Protections for Dialysis Patients Act; issues related to home dialysis.
Restore Protections for Dialysis Patients Act
Client: DAVITA INC. · Firm: WEST FRONT STRATEGIES LLC
Issues related to the Medicare Secondary Payer Act, including HR 6860 and S. 5018, Restore Protections for Dialysis Patients Act; Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act, H.R. 5074/S. 4510; issues related to home dialysis.
Restore Protections for Dialysis Patients Act
Client: DAVITA INC. · Firm: WEST FRONT STRATEGIES LLC
Issues related to the Medicare Secondary Payer Act, including HR 6860, Restore Protections for Dialysis Patients Act; issues related to home dialysis; issues related to the National Dialysis Services Contracts.
Restore Protections for Dialysis Patients Act
Client: DAVITA INC. · Firm: WEST FRONT STRATEGIES LLC
Issues related to the Medicare Secondary Payer Act, including HR 6860, Restore Protections for Dialysis Patients Act; issues related to home dialysis; issues related to the National Dialysis Services Contracts.
To address patent thickets.
Client: FRESENIUS KABI USA LLC · Firm: WEST FRONT STRATEGIES LLC
Issues related to patent policy and reform, including to address patent thickets (HR 6986, S. 3583) and Promoting and Respecting Economically Vital American Innovation Leadership Act (S. 2220, HR 4370), and Patent Eligibility Restoration Act of 2023 (S. 2140) FDA/PTO Coordination, including Interagency Patent Coordination and Improvement Act of 2023 (S.79) and Medication Affordability and Patent Integrity Act (S. 2780, HR 5429) Prescription Pricing for the People Act of 2023 (S.113); Preserve Access to Affordable Generics and Biosimilars Act (S.142); Affordable Prescriptions for Patients Act of 2023 (S.150).
To address patent thickets.
Client: FRESENIUS KABI USA LLC · Firm: WEST FRONT STRATEGIES LLC
Issues related to patent policy and reform, including to address patent thickets (HR 6986, S. 3583) and Promoting and Respecting Economically Vital American Innovation Leadership Act (S. 2220, HR 4370), and Patent Eligibility Restoration Act of 2023 (S. 2140) FDA/PTO Coordination, including Interagency Patent Coordination and Improvement Act of 2023 (S.79) and Medication Affordability and Patent Integrity Act (S. 2780, HR 5429) Prescription Pricing for the People Act of 2023 (S.113); Preserve Access to Affordable Generics and Biosimilars Act (S.142); Affordable Prescriptions for Patients Act of 2023 (S.150).
To address patent thickets.
Client: FRESENIUS KABI USA LLC · Firm: WEST FRONT STRATEGIES LLC
Issues related to patent policy and reform, including to address patent thickets (HR 6986, S. 3583) and Promoting and Respecting Economically Vital American Innovation Leadership Act (S. 2220, HR 4370), and Patent Eligibility Restoration Act of 2023 (S. 2140) FDA/PTO Coordination, including Interagency Patent Coordination and Improvement Act of 2023 (S.79) and Medication Affordability and Patent Integrity Act (S. 2780, HR 5429) Prescription Pricing for the People Act of 2023 (S.113); Preserve Access to Affordable Generics and Biosimilars Act (S.142); Affordable Prescriptions for Patients Act of 2023 (S.150).
To address patent thickets.
Client: FRESENIUS KABI USA LLC · Firm: WEST FRONT STRATEGIES LLC
Issues related to patent policy and reform, including to address patent thickets (HR 6986, S. 3583) and Promoting and Respecting Economically Vital American Innovation Leadership Act (S. 2220, HR 4370), and Patent Eligibility Restoration Act of 2023 (S. 2140) FDA/PTO Coordination, including Interagency Patent Coordination and Improvement Act of 2023 (S.79) and Medication Affordability and Patent Integrity Act (S. 2780, HR 5429) Prescription Pricing for the People Act of 2023 (S.113); Preserve Access to Affordable Generics and Biosimilars Act (S.142); Affordable Prescriptions for Patients Act of 2023 (S.150).
Tax Relief for American Families and Workers Act of 2024
Client: RTX CORPORATION AND AFFILIATES · Firm: WEST FRONT STRATEGIES LLC
Issues related to the aerospace and defense technology industry, including appropriations, tax (Tax Relief for American Families and Workers Act of 2024, HR 7024), and the National Defense Authorization Act.
Tax Relief for American Families and Workers Act of 2024
Client: RTX CORPORATION AND AFFILIATES · Firm: WEST FRONT STRATEGIES LLC
Issues related to the aerospace and defense technology industry, including appropriations, tax (Tax Relief for American Families and Workers Act of 2024, HR 7024), and the National Defense Authorization Act.
Tax Relief for American Families and Workers Act of 2024
Client: RTX CORPORATION AND AFFILIATES · Firm: WEST FRONT STRATEGIES LLC
Issues related to the aerospace and defense technology industry, including appropriations, tax (Tax Relief for American Families and Workers Act of 2024, HR 7024), and the National Defense Authorization Act.
Tax Relief for American Families and Workers Act of 2024
Client: RTX CORPORATION AND AFFILIATES · Firm: WEST FRONT STRATEGIES LLC
Issues related to the aerospace and defense technology industry, including appropriations, tax (Tax Relief for American Families and Workers Act of 2024, HR 7024), and the National Defense Authorization Act.
Children and Teens’ Online Privacy Protection Act
Client: CONSUMER TECHNOLOGY ASSOCIATION · Firm: WEST FRONT STRATEGIES LLC
Monitor issues related to consumer data privacy, including the American Privacy Rights Act of 2024 (HR 8818), Kids Online Safety Act (S. 3663 and HR 7891); and, Children and Teens Online Privacy Protection Act (S. 1418 and HR 7890).
Children and Teens’ Online Privacy Protection Act
Client: CONSUMER TECHNOLOGY ASSOCIATION · Firm: WEST FRONT STRATEGIES LLC
Monitor issues related to consumer data privacy, including the American Privacy Rights Act of 2024 (HR 8818), Kids Online Safety Act (S. 3663 and HR 7891); and, Children and Teens Online Privacy Protection Act (S. 1418 and HR 7890).
Children and Teens’ Online Privacy Protection Act
Client: CONSUMER TECHNOLOGY ASSOCIATION · Firm: WEST FRONT STRATEGIES LLC
Monitor issues related to consumer data privacy, including the American Privacy Rights Act of 2024 (HR 8818), Kids Online Safety Act (S. 3663 and HR 7891); and, Children and Teens Online Privacy Protection Act (S. 1418 and HR 7890).
Kids Online Safety Act
Client: CONSUMER TECHNOLOGY ASSOCIATION · Firm: WEST FRONT STRATEGIES LLC
Monitor issues related to consumer data privacy, including the American Privacy Rights Act of 2024 (HR 8818), Kids Online Safety Act (S. 3663 and HR 7891); and, Children and Teens Online Privacy Protection Act (S. 1418 and HR 7890).
Kids Online Safety Act
Client: CONSUMER TECHNOLOGY ASSOCIATION · Firm: WEST FRONT STRATEGIES LLC
Monitor issues related to consumer data privacy, including the American Privacy Rights Act of 2024 (HR 8818), Kids Online Safety Act (S. 3663 and HR 7891); and, Children and Teens Online Privacy Protection Act (S. 1418 and HR 7890).
Kids Online Safety Act
Client: CONSUMER TECHNOLOGY ASSOCIATION · Firm: WEST FRONT STRATEGIES LLC
Monitor issues related to consumer data privacy, including the American Privacy Rights Act of 2024 (HR 8818), Kids Online Safety Act (S. 3663 and HR 7891); and, Children and Teens Online Privacy Protection Act (S. 1418 and HR 7890).
Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: WEST FRONT STRATEGIES LLC
Issues related to the distribution of health care products; issues related to pandemic preparedness, including reauthorization of the Pandemic and All Hazards Preparedness Act; issues related to supply chain security and transportation of medical supplies; issues related to the expedition of critical medical supplies at US ports, including FAST PASS Act - HR 6140, and Section 3522 of Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 - H.R. 8070.
Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025
Client: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION · Firm: WEST FRONT STRATEGIES LLC
Issues related to the distribution of health care products; issues related to pandemic preparedness, including reauthorization of the Pandemic and All Hazards Preparedness Act; issues related to supply chain security and transportation of medical supplies; issues related to the expedition of critical medical supplies at US ports, including FAST PASS Act - HR 6140, and Section 3522 of Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 - H.R. 8070.
Increasing Mental Health Options Act of 2024
Client: AMERICAN PSYCHOLOGICAL ASSOCIATION SERVICES, INC. (FKA APA PRACTICE ORG.) · Firm: WEST FRONT STRATEGIES LLC
Legislation to amend the definition of physician in Medicare to provide for treatment of clinical psychologists as physicians, for purposes of providing clinical psychologist services under Medicare, including Increasing Mental Health Options Act (S. 699 and HR 8458); Accelerating the Development of Advanced Psychology Trainees (ADAPT) Act (S.2511 and HR 9138); issues related to reimbursement of psychologists in Medicare; issues related to integration of behavorial health services in primary care.
Increasing Mental Health Options Act of 2024
Client: AMERICAN PSYCHOLOGICAL ASSOCIATION SERVICES, INC. (FKA APA PRACTICE ORG.) · Firm: WEST FRONT STRATEGIES LLC
Legislation to amend the definition of physician in Medicare to provide for treatment of clinical psychologists as physicians, for purposes of providing clinical psychologist services under Medicare, including Increasing Mental Health Options Act (S. 699 and HR 8458); Accelerating the Development of Advanced Psychology Trainees (ADAPT) Act (S.2511); issues related to reimbursement of psychologists in Medicare; issues related to integration of behavorial health services in primary care.
Increasing Mental Health Options Act of 2024
Client: AMERICAN PSYCHOLOGICAL ASSOCIATION SERVICES, INC. (FKA APA PRACTICE ORG.) · Firm: WEST FRONT STRATEGIES LLC
Legislation to amend the definition of physician in Medicare to provide for treatment of clinical psychologists as physicians, for purposes of providing clinical psychologist services under Medicare, including Increasing Mental Health Options Act (S. 699 and HR 8458); Accelerating the Development of Advanced Psychology Trainees (ADAPT) Act (S.2511 and HR 9138); issues related to reimbursement of psychologists in Medicare; issues related to integration of behavorial health services in primary care.
American Privacy Rights Act of 2024
Client: CONSUMER TECHNOLOGY ASSOCIATION · Firm: WEST FRONT STRATEGIES LLC
Monitor issues related to consumer data privacy, including the American Privacy Rights Act of 2024 (HR 8818), Kids Online Safety Act (S. 3663 and HR 7891); and, Children and Teens Online Privacy Protection Act (S. 1418 and HR 7890).
American Privacy Rights Act of 2024
Client: NATIONAL INSURANCE CRIME BUREAU · Firm: WEST FRONT STRATEGIES LLC
Issues related to consumer data privacy, including the American Privacy Rights Act, HR 8818.
American Privacy Rights Act of 2024
Client: CONSUMER TECHNOLOGY ASSOCIATION · Firm: WEST FRONT STRATEGIES LLC
Monitor issues related to consumer data privacy, including the American Privacy Rights Act of 2024 (HR 8818), Kids Online Safety Act (S. 3663 and HR 7891); and, Children and Teens Online Privacy Protection Act (S. 1418 and HR 7890).
American Privacy Rights Act of 2024
Client: NATIONAL INSURANCE CRIME BUREAU · Firm: WEST FRONT STRATEGIES LLC
Monitor issues related to consumer data privacy, including the American Privacy Rights Act, HR 8818.
American Privacy Rights Act of 2024
Client: CONSUMER TECHNOLOGY ASSOCIATION · Firm: WEST FRONT STRATEGIES LLC
Monitor issues related to consumer data privacy, including the American Privacy Rights Act of 2024 (HR 8818), Kids Online Safety Act (S. 3663 and HR 7891); and, Children and Teens Online Privacy Protection Act (S. 1418 and HR 7890).
ADAPT Act
Client: AMERICAN PSYCHOLOGICAL ASSOCIATION SERVICES, INC. (FKA APA PRACTICE ORG.) · Firm: WEST FRONT STRATEGIES LLC
Legislation to amend the definition of physician in Medicare to provide for treatment of clinical psychologists as physicians, for purposes of providing clinical psychologist services under Medicare, including Increasing Mental Health Options Act (S. 699 and HR 8458); Accelerating the Development of Advanced Psychology Trainees (ADAPT) Act (S.2511 and HR 9138); issues related to reimbursement of psychologists in Medicare; issues related to integration of behavorial health services in primary care.
ADAPT Act
Client: AMERICAN PSYCHOLOGICAL ASSOCIATION SERVICES, INC. (FKA APA PRACTICE ORG.) · Firm: WEST FRONT STRATEGIES LLC
Legislation to amend the definition of physician in Medicare to provide for treatment of clinical psychologists as physicians, for purposes of providing clinical psychologist services under Medicare, including Increasing Mental Health Options Act (S. 699 and HR 8458); Accelerating the Development of Advanced Psychology Trainees (ADAPT) Act (S.2511 and HR 9138); issues related to reimbursement of psychologists in Medicare; issues related to integration of behavorial health services in primary care.
RESTORE Patent Rights Act of 2024
Client: UNITED FOR PATENT REFORM · Firm: WEST FRONT STRATEGIES LLC
Issues relating to patent policy including Inter Partes Review and institution decisions, patent quality, communication between patent examiners and the Patent Trial and Appeal Board (PTAB), PTAB generally, and patent eligibility; Patent Eligibility Restoration Act of 2023 (S. 2140 and HR 9474); Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (S. 2220 and HR 4370); RESTORE Patent Rights Act of 2024 (S. 4840 and HR 9221).
RESTORE Patent Rights Act of 2024
Client: UNITED FOR PATENT REFORM · Firm: WEST FRONT STRATEGIES LLC
Issues relating to patent policy including Inter Partes Review and institution decisions, patent quality, communication between patent examiners and the Patent Trial and Appeal Board (PTAB), PTAB generally, and patent eligibility; Patent Eligibility Restoration Act of 2023 (S. 2140 and HR 9474); Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (S. 2220 and HR 4370); RESTORE Patent Rights Act of 2024 (S. 4840 and HR 9221).
Issues related to proposed FDA dietary guidelines for alcohol.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BROWN-FORMAN via WEST FRONT STRATEGIES LLC
2025 · third_quarter · Q3
Issues related to tariffs, including duty drawbacks
Issues related to corporate tax policy.
Issues related to proposed FDA dietary guidelines for alcohol.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BROWN-FORMAN via WEST FRONT STRATEGIES LLC
2025 · second_quarter · Q2
Issues related to tariffs, including duty drawbacks
Issues related to corporate tax policy.
Issues related to proposed FDA dietary guidelines for alcohol.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BROWN-FORMAN via WEST FRONT STRATEGIES LLC
2025 · first_quarter · Q1
Issues related to tariffs, including duty drawbacks
Issues related to corporate tax policy.
Issues related to proposed FDA dietary guidelines for alcohol.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LOWE'S COMPANIES INC. via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Monitor implementation of Department of Energy consumer rebate programs.
Monitor issues related to organized retail crime, including the Combatting Organized Retail Crime Act, S. 140 and Organized Retail Crime Center Authorization Act of 2023, S. 139.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC. via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Issues related to the Medicare Secondary Payer Act, including HR 6860 and S. 5018, Restore Protections for Dialysis Patients Act; Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act, H.R. 5074/S. 4510; issues related to home dialysis.
Issues related to the National Dialysis Services Contracts.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN CO. via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Issues related to pharmacy, military pharmacies, pharmacist provider status, and Medicare reimbursement, including Equitable Community Access to Pharmacist Services Act (H.R. 1770 and S. 2477).
Monitor issues related to consumer data privacy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIZIO via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Monitor issues related to ATSC 3.0 and artificial intelligence.
Monitor issues related to consumer data privacy.
Monitor issues related to patent policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIATRIS INC via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Issues related to e-labeling.
Issues related to drug pricing; issues related to pharmaceutical supply chain; issues related to modernization of prescribing information for physicians and pharmacists; Improved Access to Affordable Medications Act, S. 1120; Increasing Transparency in Generic Drug Applications, S.775 and HR 3839; Part D Formulary Design and Generic Drug Tiering; Prescription Information Modernization Act, HR 1503.
Medicaid Rebate provision of the Bipartisan Budget Act of 2015 (CPI Penalty).
VELATURA PUBLIC BENEFIT CORPORATION via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Issues related to health information technology, health data utilities, and health information exchanges, Labor/Health and Human Services Appropriations.
Issues related to health information technology, health data utilities, and health information exchanges.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VAPOR TECHNOLOGY ASSOCIATION via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Issues related to the regulation of vapor products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED FOR PATENT REFORM via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Issues relating to patent policy including Inter Partes Review and institution decisions, patent quality, communication between patent examiners and the Patent Trial and Appeal Board (PTAB), PTAB generally, and patent eligibility; Patent Eligibility Restoration Act of 2023 (S. 2140 and HR 9474); Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (S. 2220 and HR 4370); RESTORE Patent Rights Act of 2024 (S. 4840 and HR 9221).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE CHICAGO SCHOOL OF PROFESSIONAL PSYCHOLOGY via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Issues relating to mental health and funding for universities and psychology students.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
RTX CORPORATION AND AFFILIATES via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Issues related to the aerospace and defense technology industry, including appropriations, tax, and the National Defense Authorization Act.
Issues related to the aerospace and defense technology industry, including appropriations, tax, and the National Defense Authorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPUBLIC SERVICES, INC. via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Issues related to renewable energy tax credits and carbon capture, including 45Q and provisions related to electric vehicles.
Issues related to Per- and polyfluoroalkyl substances (PFAS), including the Resource Management PFAS Liability Protection Act of 2023 (S. 1429) and the National Defense Authorization Act; issues related to recycling policy.
Issues related to renewable energy and waste management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRUDENTIAL FINANCIAL, INC. via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Monitor issues related to pension plans, issues related to artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE PNC FINANCIAL SERVICES GROUP via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Monitor issues impacting the financial services industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL INSURANCE CRIME BUREAU via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Monitor issues related to consumer data privacy, including the American Privacy Rights Act, HR 8818.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MICROSOFT CORPORATION via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act, S 2220. Patent Eligibility Restoration Act of 2023, S. 2140.
Issues related to emerging technologies; artificial intelligence; cloud computing; supply chain security; Section 230 of the Communications Act of 1934; and, privacy; legislative proposals related to government surveillance and data collection, including issues of transparency and ECPA reform.
Issues related to antitrust and competition policy.
INTERNATIONAL LEGAL FINANCE ASSOCIATION via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Issues related to commercial legal finance.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Issues related to the distribution of health care products; issues related to pandemic preparedness, including reauthorization of the Pandemic and All Hazards Preparedness Act; issues related to supply chain security and transportation of medical supplies; issues related to the expedition of critical medical supplies at US ports, including FAST PASS Act - HR 6140, and Section 3522 of Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 - H.R. 8070.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS KABI USA LLC via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Formulary placement of generics and biosimilar biological products in Part D; issues related to access to biosimilar biological products in Medicare Part B; issues related to rebate walls.
Issues related to patent policy and reform, including to address patent thickets (HR 6986, S. 3583) and Promoting and Respecting Economically Vital American Innovation Leadership Act (S. 2220, HR 4370), and Patent Eligibility Restoration Act of 2023 (S. 2140) FDA/PTO Coordination, including Interagency Patent Coordination and Improvement Act of 2023 (S.79) and Medication Affordability and Patent Integrity Act (S. 2780, HR 5429) Prescription Pricing for the People Act of 2023 (S.113); Preserve Access to Affordable Generics and Biosimilars Act (S.142); Affordable Prescriptions for Patients Act of 2023 (S.150).
EXPEDIA, INC. via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Monitor issues related to antitrust and competition policy.
Monitor issues related to consumer data privacy; proposed FTC rulemaking related to unfair or deceptive fees.
Monitor issues related to the online travel industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CTIA - THE WIRELESS ASSOCIATION via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Issues related to wireless policy, including spectrum, broadband funding, 5G, and privacy; issues related to the use of contraband phones in correctional facilities, including End Cells in Cells, HR 3949; Cooper Davis Act, S. 1080; issues related to the Affordable Connectivity Program issues related to net neutrality regulation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER TECHNOLOGY ASSOCIATION via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Monitor issues related to antitrust.
Monitor issues related to consumer data privacy, including the American Privacy Rights Act of 2024 (HR 8818), Kids Online Safety Act (S. 3663 and HR 7891); and, Children and Teens Online Privacy Protection Act (S. 1418 and HR 7890).
Monitor issues related to artificial intelligence.
COALITION OF MANUFACTURERS OF SMOKING ALTERNATIVES via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Education regarding consistent and transparent regulation of non-combustible tobacco and/or nicotine products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CIGAR ASSOCIATION OF AMERICA via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Education regarding the cigar industry; monitoring of FDA regulation of cigar industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENTER FOR RESPONSIBLE LENDING via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Issues related to veterans' eligibility for certain housing loans.
Issues related to industrial loan companies; issues related to the Consumer Financial Protection Bureau; issues related to small business data collection.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BROWN-FORMAN via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · Q4
Issues related to proposed FDA dietary guidelines for alcohol.
Issues related to tariffs, including duty drawbacks; Duty Drawback Clarification Act (S. 1781 and HR 4073).
Issues related to corporate tax policy, including duty drawbacks; Duty Drawback Clarification Act (S. 1781 and HR 4073).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRIGHTHOUSE FINANCIAL via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
General tax policy related to the life insurance and annuity industries.
Monitor issues related to the financial services industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN PSYCHOLOGICAL ASSOCIATION SERVICES, INC. (FKA APA PRACTICE ORG.) via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Issues related to research activities at the Department of Veterans Affairs; issues related to mental health services for veterans, including Veterans' Health Empowerment, Access, Leadership, and Transparency for our Heroes (HEALTH) Act of 2023 (S. 1315).
Legislation to amend the definition of physician in Medicare to provide for treatment of clinical psychologists as physicians, for purposes of providing clinical psychologist services under Medicare, including Increasing Mental Health Options Act (S. 699 and HR 8458); Accelerating the Development of Advanced Psychology Trainees (ADAPT) Act (S.2511 and HR 9138); issues related to reimbursement of psychologists in Medicare; issues related to integration of behavorial health services in primary care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR SAFETY AND JUSTICE via WEST FRONT STRATEGIES LLC
2024 · fourth_quarter · 4T
Issues related to funding for the Crime Victims Fund; issues related to trauma recovery centers, FY 2025 Commerce Justice Science Appropriations.
Issues related to community-focused public safety, including trauma recovery centers; issues related to services and support for victims of crime.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC. via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Issues related to the National Dialysis Services Contracts.
Issues related to the Medicare Secondary Payer Act, including HR 6860 and S. 5018, Restore Protections for Dialysis Patients Act; issues related to home dialysis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOEING COMPANY via WEST FRONT STRATEGIES LLC
2024 · third_quarter · 3T
Primary Care Enhancement Act of 2023, H.R. 3029 and S. 628.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIATRIS INC via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Medicaid Rebate provision of the Bipartisan Budget Act of 2015 (CPI Penalty).
Issues related to drug pricing; issues related to pharmaceutical supply chain; issues related to modernization of prescribing information for physicians and pharmacists; Improved Access to Affordable Medications Act, S. 1120; Increasing Transparency in Generic Drug Applications, S.775 and HR 3839; Part D Formulary Design and Generic Drug Tiering; Prescription Information Modernization Act, HR 1503.
Issues related to Inter Partes Review and patent policy generally; Preserve Access to Affordable Generics and Biosimilars Act, S.142; Affordable Prescriptions for Patients Act, S. 150 Issues related to FDA and PTO coordination, including, Interagency Patent Coordination and Improvement Act of 2023, S. 79 and HR 1717, and Medication Affordability and Patent Integrity Act, S.2780 and HR 5429; PREVAIL Act, S.2220 and HR 4370; Patent Eligibility Restoration Act of 2023, S.2140.
VAPOR TECHNOLOGY ASSOCIATION via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Issues related to the regulation of vapor products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RTX CORPORATION AND AFFILIATES via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Issues related to the aerospace and defense technology industry, including appropriations, tax, and the National Defense Authorization Act.
Issues related to the aerospace and defense technology industry, including appropriations, tax, and the National Defense Authorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRUDENTIAL FINANCIAL, INC. via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Monitor issues related to pension plans, issues related to artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MICROSOFT CORPORATION via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Issues related to consumer and children's privacy, including S. 1409, Kids Online Safety Act; S. 1418, Children and Teens Online Privacy Protection 2.0 Reform Act; and S. 2708, Deceptive Experiences To Online Users Reduction Act.
Issues related to emerging technologies; artificial intelligence; cloud computing; supply chain security; Section 230 of the Communications Act of 1934; and, privacy; legislative proposals related to government surveillance and data collection, including issues of transparency and ECPA reform.
Issues related to antitrust and competition policy.
LOWE'S COMPANIES INC. via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Monitor implementation of Department of Energy consumer rebate programs.
Monitor issues related to organized retail crime, including the Combatting Organized Retail Crime Act, S. 140 and Organized Retail Crime Center Authorization Act of 2023, S. 139.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL LEGAL FINANCE ASSOCIATION via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Issues related to commercial legal finance.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS KABI USA LLC via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Issues related to patent policy and reform, including to address patent thickets (HR 6986, S. 3583) and Promoting and Respecting Economically Vital American Innovation Leadership Act (S. 2220, HR 4370), and Patent Eligibility Restoration Act of 2023 (S. 2140) FDA/PTO Coordination, including Interagency Patent Coordination and Improvement Act of 2023 (S.79) and Medication Affordability and Patent Integrity Act (S. 2780, HR 5429) Prescription Pricing for the People Act of 2023 (S.113); Preserve Access to Affordable Generics and Biosimilars Act (S.142); Affordable Prescriptions for Patients Act of 2023 (S.150).
Formulary placement of generics and biosimilar biological products in Part D; issues related to access to biosimilar biological products in Medicare Part B; issues related to rebate walls.
EXPEDIA, INC. via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Monitor issues related to the online travel industry.
Monitor issues related to consumer data privacy; proposed FTC rulemaking related to unfair or deceptive fees.
Monitor issues related to antitrust and competition policy.
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
CTIA - THE WIRELESS ASSOCIATION via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Issues related to wireless policy, including spectrum, broadband funding, 5G, and privacy; issues related to the use of contraband phones in correctional facilities, including End Cells in Cells, HR 3949; Cooper Davis Act, S. 1080; issues related to the Affordable Connectivity Program issues related to net neutrality regulation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER TECHNOLOGY ASSOCIATION via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
AM Radio for Every Vehicle Act of 2023 (H.R.3413 and S. 1669); monitor issues related to Section 230 of the Communications Act of 1934.
Issues related to Section 301 tariff exclusions.
Issues related to patent law, including the Promoting and Respecting Economically Vital American Innovation Leadership (S. 2220 and HR 4370) and the Patent Eligibility Restoration Act (S. 2140).
COALITION OF MANUFACTURERS OF SMOKING ALTERNATIVES via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Education regarding consistent and transparent regulation of non-combustible tobacco and/or nicotine products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CIGAR ASSOCIATION OF AMERICA via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Education regarding the cigar industry; monitoring of FDA regulation of cigar industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BROWN-FORMAN via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Issues related to corporate tax policy, including duty drawbacks; Duty Drawback Clarification Act (S. 1781 and HR 4073).
Issues related to tariffs, including duty drawbacks; Duty Drawback Clarification Act (S. 1781 and HR 4073).
Issues related to proposed FDA dietary guidelines for alcohol.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRIGHTHOUSE FINANCIAL via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
General tax policy related to the life insurance and annuity industries.
Monitor issues related to the financial services industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN PSYCHOLOGICAL ASSOCIATION SERVICES, INC. (FKA APA PRACTICE ORG.) via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Issues related to research activities at the Department of Veterans Affairs; issues related to mental health services for veterans, including Veterans' Health Empowerment, Access, Leadership, and Transparency for our Heroes (HEALTH) Act of 2023 (S. 1315).
Legislation to amend the definition of physician in Medicare to provide for treatment of clinical psychologists as physicians, for purposes of providing clinical psychologist services under Medicare, including Increasing Mental Health Options Act (S. 699 and HR 8458); Accelerating the Development of Advanced Psychology Trainees (ADAPT) Act (S.2511 and HR 9138); issues related to reimbursement of psychologists in Medicare; issues related to integration of behavorial health services in primary care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR SAFETY AND JUSTICE via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Issues related to community-focused public safety, including trauma recovery centers; issues related to services and support for victims of crime.
Issues related to funding for the Crime Victims Fund; issues related to trauma recovery centers, FY 2025 Commerce Justice Science Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN CO. via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Monitor issues related to consumer data privacy.
Issues related to pharmacy, military pharmacies, pharmacist provider status, and Medicare reimbursement, including Equitable Community Access to Pharmacist Services Act (H.R. 1770 and S. 2477).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIZIO via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Monitor issues related to patent policy.
Monitor issues related to ATSC 3.0 and artificial intelligence.
Monitor issues related to consumer data privacy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VELATURA PUBLIC BENEFIT CORPORATION via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Issues related to health information technology and health information exchanges, Labor/Health and Human Services Appropriations.
Issues related to health information technology and health information exchanges.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNITED FOR PATENT REFORM via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Issues relating to patent policy including Inter Partes Review and institution decisions, patent quality, communication between patent examiners and the Patent Trial and Appeal Board (PTAB), PTAB generally, and patent eligibility; Patent Eligibility Restoration Act of 2023 (S. 2140 and HR 9474); Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (S. 2220 and HR 4370); RESTORE Patent Rights Act of 2024 (S. 4840 and HR 9221).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE PNC FINANCIAL SERVICES GROUP via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Monitor issues impacting the financial services industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE CHICAGO SCHOOL OF PROFESSIONAL PSYCHOLOGY via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Issues relating to mental health and funding for universities and psychology students.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE
REPUBLIC SERVICES, INC. via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Issues related to renewable energy and waste management.
Issues related to renewable energy tax credits and carbon capture, including 45Q and provisions related to electric vehicles.
Issues related to Per- and polyfluoroalkyl substances (PFAS), including the Resource Management PFAS Liability Protection Act of 2023 (S. 1429) and the National Defense Authorization Act; issues related to recycling policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PLEASE TOUCH MUSEUM via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Community project funding related to Innovation and Improvement grants under the Department of Education in Fiscal Year 2025 Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL INSURANCE CRIME BUREAU via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Issues related to consumer data privacy, including the American Privacy Rights Act, HR 8818.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Issues related to the distribution of health care products; issues related to pandemic preparedness, including reauthorization of the Pandemic and All Hazards Preparedness Act; issues related to supply chain security and transportation of medical supplies; issues related to the expedition of critical medical supplies at US ports, including FAST PASS Act - HR 6140, and Section 3522 of Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 - H.R. 8070.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENTER FOR RESPONSIBLE LENDING via WEST FRONT STRATEGIES LLC
2024 · third_quarter · Q3
Issues related to veterans' eligibility for certain housing loans.
Issues related to industrial loan companies; issues related to the Consumer Financial Protection Bureau; issues related to small business data collection.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMCAST CORPORATION via WEST FRONT STRATEGIES LLC
2024 · second_quarter · 2T
Issues related to consumer privacy and children's online privacy.
Issues related to consumer privacy; issues related to broadband, including funding, and rural deployment; Affordable Connectivity Program.
Issues related to antitrust reform.
EXPEDIA, INC. via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Monitor issues related to the online travel industry.
Monitor issues related to antitrust and competition policy.
Monitor issues related to consumer data privacy; proposed FTC rulemaking related to unfair or deceptive Fees.
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
WALGREEN CO. via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Monitor issues related to consumer data privacy.
Issues related to pharmacy, military pharmacies, pharmacist provider status, and Medicare reimbursement, including Equitable Community Access to Pharmacist Services Act (H.R. 1770 and S. 2447)).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIZIO via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Monitor issues related to ATSC 3.0 and artificial intelligence.
Issues related to consumer data privacy.
Monitor issues related to patent policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIATRIS INC via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Medicaid Rebate provision of the Bipartisan Budget Act of 2015 (CPI Penalty).
Issues related to e-labeling; monitor issues related to Pharmacy Benefit Manager Transparency Act, S.127.
Issues related to access to biosimilar biological products in Medicare Part B, including the Increasing Access to Biosimilars Act, H.R. 1352.
VELATURA PUBLIC BENEFIT CORPORATION via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Issues related to health information technology and health information exchanges.
Issues related to health information technology and health information exchanges, Labor/Health and Human Services Appropriations.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VAPOR TECHNOLOGY ASSOCIATION via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Issues related to the regulation of vapor products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED FOR PATENT REFORM via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Issues relating to patent policy including Inter Partes Review and institution decisions, patent quality, communication between patent examiners and the Patent Trial and Appeal Board (PTAB), PTAB generally, and patent eligibility; Patent Eligibility Restoration Act of 2023 (S. 2140); Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (S. 2220).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE CHICAGO SCHOOL OF PROFESSIONAL PSYCHOLOGY via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Issues relating to mental health and funding for universities and psychology students.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
RTX CORPORATION AND AFFILIATES via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Issues related to the aerospace and defense technology industry, including appropriations, tax (Tax Relief for American Families and Workers Act of 2024, HR 7024), and the National Defense Authorization Act.
Issues related to the aerospace and defense technology industry, including appropriations, tax (Tax Relief for American Families and Workers Act of 2024, HR 7024), and the National Defense Authorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPUBLIC SERVICES, INC. via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Issues related to Per- and polyfluoroalkyl substances (PFAS), including the Resource Management PFAS Liability Protection Act of 2023 (S. 1429) and the National Defense Authorization Act; issues related to recycling policy.
Issues related to renewable energy and waste management.
Issues related to renewable energy tax credits and carbon capture, including 45Q and provisions related to electric vehicles.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRUDENTIAL FINANCIAL, INC. via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Monitor issues related to pension plans, issues related to artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PLEASE TOUCH MUSEUM via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Community project funding related to Innovation and Improvement grants under the Department of Education in Fiscal Year 2025 Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE PNC FINANCIAL SERVICES GROUP via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Monitor issues impacting the financial services industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OLEARY PRODUCTIONS USA LLC via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Issues related to support and opportunities for small business.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL INSURANCE CRIME BUREAU via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Issues related to consumer data privacy, including the American Privacy Rights Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MICROSOFT CORPORATION via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Nurture Originals, Foster Art, and Keep Entertainment Safe (NO FAKES) Act
Issues related to antitrust and competition policy.
Issues related to emerging technologies; artificial intelligence; cloud computing; supply chain security; Section 230 of the Communications Act of 1934; and, privacy; legislative proposals related to government surveillance and data collection, including issues of transparency and ECPA reform.
LOWE'S COMPANIES INC. via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Monitor implementation of Department of Energy consumer rebate programs.
Monitor issues related to organized retail crime, including the Combatting Organized Retail Crime Act, S. 140 and Organized Retail Crime Center Authorization Act of 2023, S. 139.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL LEGAL FINANCE ASSOCIATION via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Issues related to commercial legal finance.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Issues related to the distribution of health care products; issues related to pandemic preparedness, including reauthorization of the Pandemic and All Hazards Preparedness Act; issues related to supply chain security and transportation of medical supplies; issues related to the expedition of critical medical supplies at US ports including FAST PASS Act (HR 6140).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS KABI USA LLC via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Issues related to patent policy and reform, including to address patent thickets (HR 6986, S. 3583) and Promoting and Respecting Economically Vital American Innovation Leadership Act (S. 2220, HR 4370), and Patent Eligibility Restoration Act of 2023 (S. 2140) FDA/PTO Coordination, including Interagency Patent Coordination and Improvement Act of 2023 (S.79) and Medication Affordability and Patent Integrity Act (S. 2780, HR 5429) Prescription Pricing for the People Act of 2023 (S.113); Preserve Access to Affordable Generics and Biosimilars Act (S.142); Affordable Prescriptions for Patients Act of 2023 (S.150).
Formulary placement of generics and biosimilar biological products in Part D; issues related to access to biosimilar biological products in Medicare Part B; issues related to rebate walls.
DAVITA INC. via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Issues related to the Medicare Secondary Payer Act, including HR 6860, Restore Protections for Dialysis Patients Act; issues related to home dialysis; issues related to the National Dialysis Services Contracts.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CTIA - THE WIRELESS ASSOCIATION via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Monitor issues related to wireless policy, including broadband funding, 5G, and privacy; issues related to the use of contraband phones in correctional facilities, including End Cells in Cells, HR 3949 and Cooper Davis Act, S. 1080; issues related to the Affordable Connectivity Program issues related to net neutrality regulation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER TECHNOLOGY ASSOCIATION via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
AM Radio for Every Vehicle Act of 2023 (H.R.3413 and S. 1669); monitor issues related to Section 230 of the Communications Act of 1934.
Monitor issues related to consumer data privacy, including the American Privacy Rights Act of 2024 (HR 8818), Kids Online Safety Act (S. 3663 and HR 7891); and, Children and Teens Online Privacy Protection Act (S. 1418 and HR 7890).
Monitor S. 1199, STOP CSAM Act of 2023; S. 1080, Cooper Davis Act; and, S. 1207, EARN IT Act of 2023.
COALITION OF MANUFACTURERS OF SMOKING ALTERNATIVES via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Education regarding consistent and transparent regulation of non-combustible tobacco and/or nicotine products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CIGAR ASSOCIATION OF AMERICA via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Education regarding the cigar industry; monitoring of FDA regulation of cigar industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENTER FOR RESPONSIBLE LENDING via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Issues related to veterans' eligibility for certain housing loans.
Issues related to industrial loan companies; issues related to the Consumer Financial Protection Bureau; issues related to small business data collection.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BROWN-FORMAN via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Issues related to corporate tax policy, including duty drawbacks; Duty Drawback Clarification Act (S. 1781 and HR 4073).
Issues related to tariffs, including duty drawbacks; Duty Drawback Clarification Act (S. 1781 and HR 4073).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRIGHTHOUSE FINANCIAL via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Monitor issues related to the financial services industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOEING COMPANY via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Primary Care Enhancement Act of 2023, H.R. 3029 and S. 628.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLINK HEALTH INC. via WEST FRONT STRATEGIES LLC
2024 · second_quarter · 2T
Monitor issues related to competition in pharmacy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN PSYCHOLOGICAL ASSOCIATION SERVICES, INC. (FKA APA PRACTICE ORG.) via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Issues related to research activities at the Department of Veterans Affairs; issues related to mental health services for veterans, including Veterans' Health Empowerment, Access, Leadership, and Transparency for our Heroes (HEALTH) Act of 2023 (S. 1315).
Legislation to amend the definition of physician in Medicare to provide for treatment of clinical psychologists as physicians, for purposes of providing clinical psychologist services under Medicare, including Increasing Mental Health Options Act (S. 699 and HR 8458); Accelerating the Development of Advanced Psychology Trainees (ADAPT) Act (S.2511); issues related to reimbursement of psychologists in Medicare; issues related to integration of behavorial health services in primary care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR SAFETY AND JUSTICE via WEST FRONT STRATEGIES LLC
2024 · second_quarter · Q2
Issues related to community-focused public safety, including trauma recovery centers;
Issues related to funding for the Crime Victims Fund; issues related to trauma recovery centers, FY 2025 Commerce Justice Science Appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION OF MANUFACTURERS OF SMOKING ALTERNATIVES via WEST FRONT STRATEGIES LLC
2024 · first_quarter · Q1
Education regarding consistent and transparent regulation of non-combustible tobacco and/or nicotine products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RTX CORPORATION AND AFFILIATES via WEST FRONT STRATEGIES LLC
2024 · first_quarter · Q1
Issues related to the aerospace and defense technology industry, including appropriations, tax (Tax Relief for American Families and Workers Act of 2024, HR 7024), and the National Defense Authorization Act.
Issues related to the aerospace and defense technology industry, including appropriations, tax (Tax Relief for American Families and Workers Act of 2024, HR 7024), and the National Defense Authorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIATRIS INC via WEST FRONT STRATEGIES LLC
2024 · first_quarter · Q1
Medicaid Rebate provision of the Bipartisan Budget Act of 2015 (CPI Penalty).
Issues related to Inter Partes Review and patent policy generally; Preserve Access to Affordable Generics and Biosimilars Act, S.142; Affordable Prescriptions for Patients Act, S. 150 Issues related to FDA and PTO coordination, including, Interagency Patent Coordination and Improvement Act of 2023 (S. 79 and HR 1717) and Medication Affordability and Patent Integrity Act (S.2780 and HR 5429); PREVAIL Act (S.2220 and HR 4370).
Issues related to drug pricing; issues related to pharmaceutical supply chain; issues related to modernization of prescribing information for physicians and pharmacists; Improved Access to Affordable Medications Act, S. 1120; Increasing Transparency in Generic Drug Applications, S.775 and HR 3839; Part D Formulary Design and Generic Drug Tiering; Prescription Information Modernization Act, HR 1503; and Presidents Emergency Plan for AIDS Relief Reauthorization.
WALGREEN CO. via WEST FRONT STRATEGIES LLC
2024 · first_quarter · Q1
Monitor issues related to consumer data privacy.
Issues related to pharmacy, military pharmacies, pharmacist provider status, and Medicare reimbursement, including Equitable Community Access to Pharmacist Services Act (H.R. 1770 and S. 2447)).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIZIO via WEST FRONT STRATEGIES LLC
2024 · first_quarter · Q1
Issues related to consumer data privacy.
Monitor issues related to patent policy.
Monitor issues related to ATSC 3.0 and artificial intelligence.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Inter Partes Review and patent policy generally; Preserve Access to Affordable Generics and Biosimilars Act, S.142; Affordable Prescriptions for Patients Act, S. 150 Issues related to FDA and PTO coordination, including, Interagency Patent Coordination and Improvement Act of 2023, S. 79 and HR 1717, and Medication Affordability and Patent Integrity Act, S.2780 and HR 5429; PREVAIL Act, S.2220 and HR 4370; Patent Eligibility Restoration Act of 2023, S.2140.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to consumer and children's privacy, including S. 1409, Kids Online Safety Act; S. 1418, Children and Teens Online Privacy Protection 2.0 Reform Act; and S. 2708, Deceptive Experiences To Online Users Reduction Act.
Filing targets: SENATE
Issues related to drug pricing; issues related to Biosimilars; issues related to competition; issues related to drug shortages; DRUG Act (HR 6283, S. 1542).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AM Radio for Every Vehicle Act of 2023 (H.R.3413 and S. 1669); monitor issues related to Section 230 of the Communications Act of 1934.
Issues related to Section 301 tariff exclusions.
Monitor S. 1199, STOP CSAM Act of 2023; S. 1080, Cooper Davis Act; and, S. 1207, EARN IT Act of 2023.
Issues related to patent law, including the Promoting and Respecting Economically Vital American Innovation Leadership (S. 2220 and HR 4370) and the Patent Eligibility Restoration Act (S. 2140).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to e-labeling.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act, S 2220. Patent Eligibility Restoration Act of 2023, S. 2140.
Filing targets: SENATE
Issues related to drug pricing; issues related to Biosimilars; issues related to competition; issues related to drug shortages; DRUG Act (HR 6283, S. 1542).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Monitor issues related to antitrust.
Monitor issues related to consumer data privacy, including the American Privacy Rights Act of 2024 (HR 8818), Kids Online Safety Act (S. 3663 and HR 7891); and, Children and Teens Online Privacy Protection Act (S. 1418 and HR 7890).
Monitor issues related to artificial intelligence.
Monitor S. 1199, STOP CSAM Act of 2023; S. 1080, Cooper Davis Act; and, S. 1207, EARN IT Act of 2023.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to patent reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to drug pricing; issues related to pharmaceutical supply chain; issues related to modernization of prescribing information for physicians and pharmacists; Improved Access to Affordable Medications Act, S. 1120; Increasing Transparency in Generic Drug Applications, S.775 and HR 3839; Part D Formulary Design and Generic Drug Tiering; Prescription Information Modernization Act, HR 1503; and Presidents Emergency Plan for AIDS Relief Reauthorization.
Issues related to Inter Partes Review and patent policy generally; Preserve Access to Affordable Generics and Biosimilars Act, S.142; Affordable Prescriptions for Patients Act, S. 150 Issues related to FDA and PTO coordination, including, Interagency Patent Coordination and Improvement Act of 2023 (S. 79 and HR 1717) and Medication Affordability and Patent Integrity Act (S.2780 and HR 5429); PREVAIL Act (S.2220 and HR 4370).
Monitor issues related to antitrust and competition.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to consumer and children's privacy, including S. 1409, Kids Online Safety Act; S. 1418, Children and Teens Online Privacy Protection 2.0 Reform Act; and S. 2708, Deceptive Experiences To Online Users Reduction Act.
Filing targets: SENATE
Issues related to drug pricing; issues related to Biosimilars; issues related to competition; issues related to drug shortages; DRUG Act (HR 6283, S. 1542).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Monitor issues related to artificial intelligence.
Issues related to Section 301 tariff exclusions.
Issues related to patent law, including the Promoting and Respecting Economically Vital American Innovation Leadership (S. 2220 and HR 4370) and the Patent Eligibility Restoration Act (S. 2140).
Monitor issues related to antitrust.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to access to biosimilar biological products in Medicare Part B, including the Increasing Access to Biosimilars Act, H.R. 1352.
Monitor issues related to antitrust and competition.
Issues related to e-labeling; monitor issues related to Pharmacy Benefit Manager Transparency Act, S.127.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE